Coldstream Capital Management Inc Agios Pharmaceuticals, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,365 shares of AGIO stock, worth $40,909. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,365Holding current value
$40,909% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
58.4MCall Options Held
295KPut Options Held
286K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$170 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$168 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$146 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$105 Million2.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.3MShares$69 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.64B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...